0001209191-22-043897.txt : 20220802 0001209191-22-043897.hdr.sgml : 20220802 20220802164731 ACCESSION NUMBER: 0001209191-22-043897 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220801 FILED AS OF DATE: 20220802 DATE AS OF CHANGE: 20220802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mordwinkin Nicholas Michael CENTRAL INDEX KEY: 0001937229 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38542 FILM NUMBER: 221129443 MAIL ADDRESS: STREET 1: C/O KEZAR LIFE SCIENCES, INC. STREET 2: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kezar Life Sciences, Inc. CENTRAL INDEX KEY: 0001645666 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473366145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-822-5600 MAIL ADDRESS: STREET 1: 4000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-01 0 0001645666 Kezar Life Sciences, Inc. KZR 0001937229 Mordwinkin Nicholas Michael C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Business Officer Employee Stock Option (right to buy) 9.35 2022-08-01 4 A 0 200000 0.00 A 2032-07-31 Common Stock 200000 200000 D Twenty five percent (25%) of the shares will vest on July 11, 2023, and 1/48th of the total shares will vest each month thereafter, subject to Reporting Person continuing to provide service through such date. /s/ Marc Belsky, Attorney-in-Fact 2022-08-02